Structural Formula (Pot0c 0002 01)
Potassium Chloride Injection, Solution
Product Images NDC 63323-669
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Potassium Chloride (NDC 63323-669). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fresenius Kabi Logo (Pot0c 0002 02)
Package Label (PRINCIPAL DISPLAY – Potassium Chloride in 5% Dextrose Injection, USP 10 mEq/L Bag Label)
Package Label (PRINCIPAL DISPLAY – Potassium Chloride in 5% Dextrose Injection, USP 10 mEq/L Shipper Label)
This is a description of a pharmaceutical product with the National Drug Code (NDC) 63323-667-10 667110. The product contains 10 milliequivalents of Potassium Chloride in a 5% Dextrose Injection, USP. It is manufactured and stored by KABI in Lake Zurich, IL 60047. Additionally, it is made in Norway. The product should be kept at a temperature of 20° to 25°C (68° to 77°F) and must be protected from excessive heat. The rest of the text is not legible.*
Package Label (PRINCIPAL DISPLAY – Potassium Chloride in 5% Dextrose Injection, USP 20 mEq/L Bag Label)
This is a description of a medication in the form of an injection with the brand name "Free Flex." The medication has a National Drug Code of 63323-669-01 and is in a 1000 mL container. It is intended for intravenous use only and requires a prescription. The medication contains 20 mEq of potassium chloride in 5% Dextrose Injection, USP. The electrolytes per 1000 mL are 20 mEq of potassium and 20 mEq of chloride. The container is a single-dose container and any unused portion should be discarded. It is not recommended to administer the medication simultaneously with blood. The usual dosage should be determined by the package insert. The overwrap acts as a moisture barrier. The medication should be used immediately once removed from the overwrap and stored at 20° to 25°C (68° to 77°F). The container closure is made without natural rubber latex and is sterile. The medication is manufactured for Fresenius Kabi and made in Norway. The website for the company is www.fresenius-kabi.com/us.*
Package Label (PRINCIPAL DISPLAY – Potassium Chloride in 5% Dextrose Injection, USP 20 mEq/L Shipper Label)
This is a description of a medication named Potassium Chloride meant for injection. The medicine is found in a package containing 10 packs of 1000 mL. The prescription label features the drug's National Drug Code number, dosage, and appropriate storage. There is information about the manufacturer and a batch number. The medication is meant to be kept in a controlled temperature environment and away from excessive heat. The medication is intended to be administered intravenously to provide Potassium Chloride to the body.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
